Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...

The Phase II segment is a randomised, double-blind, placebo-controlled study assessing ABCL635 efficacy in 80 postmenopausal ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

New peer-reviewed research adds to substantial body of scientific evidence highlighting the safety of natural kratom leaf ...

This clinical trial will determine whether focused ultrasound can safely and effectively treat metastatic brain tumors when ...

Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

The trial achieved its primary endpoint, showing a statistically significant reduction in Valsalva LVOT gradient at week 28.

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...

Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...

Major North Carolina CROs include IQVIA in Durham and Syneos Health in Morrisville. PPD Inc., which Thermo Fisher Scientific acquired in 2021, was headquartered in Wilmington and has an office in the ...